0000929638-25-003261.txt : 20250827 0000929638-25-003261.hdr.sgml : 20250827 20250827154453 ACCESSION NUMBER: 0000929638-25-003261 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250827 DATE AS OF CHANGE: 20250827 EFFECTIVENESS DATE: 20250827 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Xanadu Bio, Inc. CENTRAL INDEX KEY: 0001946059 ORGANIZATION NAME: EIN: 870955170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-555995 FILM NUMBER: 251264927 BUSINESS ADDRESS: STREET 1: 980 IDLEWILD ROAD CITY: GLADWYNE STATE: PA ZIP: 19035 BUSINESS PHONE: 610-937-6000 MAIL ADDRESS: STREET 1: 980 IDLEWILD ROAD CITY: GLADWYNE STATE: PA ZIP: 19035 D 1 primary_doc.xml X0708 D LIVE 0001946059 Xanadu Bio, Inc. 980 IDLEWILD ROAD GLADWYNE PA PENNSYLVANIA 19035 610-937-6000 DELAWARE None None Corporation true 2021 Bruce Turner c/o Xanadu Bio, Inc. 980 Idlewild Road Gladwyne PA PENNSYLVANIA 19035 Director Executive Officer Promoter Dr. Turner is the Chief Executive Officer, President, Treasurer and Secretary of the Issuer. Todd Wider c/o Xanadu Bio, Inc. 980 Idlewild Road Gladwyne PA PENNSYLVANIA 19035 Director Executive Officer Promoter Dr. Wider is the Chief Medical Officer of the Issuer. Mark Saltzman c/o Xanadu Bio, Inc. 980 Idlewild Road Gladwyne PA PENNSYLVANIA 19035 Director Taylor Feehley c/o Xanadu Bio, Inc. 980 Idlewild Road Gladwyne PA PENNSYLVANIA 19035 Executive Officer Dr. Feehley is the Chief Operating Officer of the Issuer. Biotechnology Decline to Disclose 06b false 2025-08-13 false true true Series B Preferred Stock false 0 10999994 10999994 0 false 4 0 0 0 false Xanadu Bio, Inc. /s/ Bruce Turner Bruce Turner Chief Executive Officer & President of the Issuer 2025-08-27